Knight Therapeutics | GUD - Market Capitalization

Stock Price
8.43
Daily Change
-0.21 -2.43%
Monthly
9.91%
Yearly
45.34%
Q2 Forecast
8.25

Knight Therapeutics reported CAD861.97M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cronos Group USD 1.43B 475.59M May/2026
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 31.35B 2.72B May/2026
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Revvity USD 11.4B 1.46B May/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 20.65B 4.92B May/2026
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025